Talk:Olaratumab
Jump to navigation
Jump to search
| This is the talk page for discussing improvements to the Olaratumab article. This is not a forum for general discussion of the article's subject. |
Article policies
|
| Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
| |||||||||||||||||||||
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Olaratumab.
|
Should mention clinical trial results
There should be at least phase 2 results that prompted the FDA accelerated approval. Some detail would be helpful ? - Rod57 (talk) 13:23, 12 December 2016 (UTC)
Done --ἀνυπόδητος (talk) 12:21, 31 December 2016 (UTC)
